// App-Quantinova.ai

281 : Clinical Outcomes of Filgotinib in Patients with RA Aged ≥65 Years: A Post Hoc Subgroup Analysis of Phase 2 and 3 Clinical Trials and Ongoing Long-Term Extensions

Researchers

Presenter

  • Maya Buch

Principal Investigators

  • BERNARD COMBE

  • Jose A Gomez-Puerta

  • Roberto Felice Caporali

  • jacques-eric gottenberg

  • Paul Van Hoek

  • Vijay Rajendran

  • Pieter-Jan Stiers

  • Katrien Van Beneden

  • Daniel Aletaha

  • Gerd Burmester

  • Rene Westhovens

  • Yoshiya Tanaka

Medical Centers

  • University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom

  • Montpellier Universitary Hospital, Montpellier, France

  • Hospital Clinic Barcelona, Barcelona, Spain

  • University of Milan, Milan, Italy

  • Strasbourg University, Strasbourg, France

  • Galapagos, Mechelen, Belgium

  • Galapagos NV, Gent, Belgium

  • Medical University of Vienna, Vienna, Austria

  • Charite-University Medicine Berlin, Berlin, Germany

  • University Hospitals Leuven and KU Leuven, Leuven, Belgium

  • University of Occupational and Environmental Health, Kitakyushu, Japan

Locations

  • United Kingdom

  • France

  • Spain

  • Italy

  • Belgium

  • Austria

  • Germany

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Filgotinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • NCT01888874

  • NCT01894516

  • NCT02889796

  • NCT02873936

  • NCT02886728

  • NCT02065700

  • NCT03025308

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved